Chemoinformaics analysis of 1,2-Octadecanediol
| Molecular Weight | 286.5 | nRot | 16 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 6 |
| Exact Molecular Weight | 286.287 | nRing | 0 |
| Solubility: LogS | -3.683 | nHRing | 0 |
| Solubility: LogP | 3.593 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 57.0021 |
| nHD | 2 | BPOL | 38.1219 |
| QED | 0.534 |
| Synth | 1.13 |
| Natural Product Likeliness | -0.969 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.242 |
| MDCK | 0.0000212 |
| BBB | 0.896 |
| PPB | 0.921096 |
| VDSS | 2.134 |
| FU | 0.0640778 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.938 |
| CYP2c19-inh | 0.899 |
| CYP2c19-sub | 0.798 |
| CYP2c9-inh | 0.578 |
| CYP2c9-sub | 0.464 |
| CYP2d6-inh | 0.671 |
| CYP2d6-sub | 0.774 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.551 |
| CL | 10.736 |
| T12 | 0.517 |
| hERG | 0.074 |
| Ames | 0.023 |
| ROA | 0.037 |
| SkinSen | 0.371 |
| Carcinogencity | 0.405 |
| EI | 0.994 |
| Respiratory | 0.066 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.571218 |